a r t I C l e S Mesencephalic and diencephalic dopaminergic (mdDA) progenitors give rise to two major subgroups corresponding to the A9 neurons of the substantia nigra pars compacta (SNpc) and the A10 neurons of the VTA [1] [2] [3] [4] [5] . SNpc neurons originate from both anterior prosomeres and mesencephalon and VTA neurons originate from mesencephalic dopaminergic (mesDA) progenitors [5] [6] [7] . MdDA neurons are crucial for the control of motor, sensorimotor and motivated behaviors 8 . Degeneration of SNpc neurons is associated with the characteristic symptoms of Parkinson's disease and abnormal functioning of VTA neurons is involved in psychiatric disorders. Relevant advances have been made in the comprehension of the molecular mechanism controlling neurogenesis and survival of mdDA neurons 4, 6, . Nevertheless, little is known about the molecular basis determining phenotypic and functional diversity between and within SNpc and VTA neurons. For example, dopamine uptake may be differentially regulated in SNpc and VTA neurons by the cellular level of the glycosylated active form of Dat (glyco-Dat), whose distribution is not uniform, but is instead preferentially restricted to SNpc and dorsal-lateral VTA neurons 30 , which are also more sensitive to the neurodegeneration induced by Parkinson's disease or MPTP toxin [30] [31] [32] [33] . Furthermore, the fact that several gene markers are expressed in specific subsets of VTA and SNpc neurons reinforces the idea that these two groups of neurons may include multiple subtypes, potentially determining a complex source of functional diversity 34, 35 . In this context, calbindin D28K (Calb) is prevalently expressed in a relevant fraction of VTA neurons, whereas the G protein-gated inwardly rectifying K + channel (Girk2) and the aldehyde dehydrogenase family 1, subfamily A1 gene, also known as Ahd2 or Aldh1a1, are both expressed in a relevant proportion of SNpc neurons and in a subset of VTA neurons 4, 7, [36] [37] [38] [39] [40] . Very little is known about the genetic function(s) controlling specification and/or maintenance of these neuronal subpopulations.
a r t I C l e S Mesencephalic and diencephalic dopaminergic (mdDA) progenitors give rise to two major subgroups corresponding to the A9 neurons of the substantia nigra pars compacta (SNpc) and the A10 neurons of the VTA [1] [2] [3] [4] [5] . SNpc neurons originate from both anterior prosomeres and mesencephalon and VTA neurons originate from mesencephalic dopaminergic (mesDA) progenitors [5] [6] [7] . MdDA neurons are crucial for the control of motor, sensorimotor and motivated behaviors 8 . Degeneration of SNpc neurons is associated with the characteristic symptoms of Parkinson's disease and abnormal functioning of VTA neurons is involved in psychiatric disorders. Relevant advances have been made in the comprehension of the molecular mechanism controlling neurogenesis and survival of mdDA neurons 4, 6, . Nevertheless, little is known about the molecular basis determining phenotypic and functional diversity between and within SNpc and VTA neurons. For example, dopamine uptake may be differentially regulated in SNpc and VTA neurons by the cellular level of the glycosylated active form of Dat (glyco-Dat), whose distribution is not uniform, but is instead preferentially restricted to SNpc and dorsal-lateral VTA neurons 30 , which are also more sensitive to the neurodegeneration induced by Parkinson's disease or MPTP toxin [30] [31] [32] [33] . Furthermore, the fact that several gene markers are expressed in specific subsets of VTA and SNpc neurons reinforces the idea that these two groups of neurons may include multiple subtypes, potentially determining a complex source of functional diversity 34, 35 . In this context, calbindin D28K (Calb) is prevalently expressed in a relevant fraction of VTA neurons, whereas the G protein-gated inwardly rectifying K + channel (Girk2) and the aldehyde dehydrogenase family 1, subfamily A1 gene, also known as Ahd2 or Aldh1a1, are both expressed in a relevant proportion of SNpc neurons and in a subset of VTA neurons 4, 7, [36] [37] [38] [39] [40] . Very little is known about the genetic function(s) controlling specification and/or maintenance of these neuronal subpopulations.
We previously concentrated our efforts on the role exerted by the transcription factor Otx2 in mdDA neurogenesis 6, [27] [28] [29] . Recently, we and others discovered that in adult mice Otx2 is expressed in a relevant subset of VTA neurons and excluded from those of the SNpc 34, 38 . In VTA neurons, Otx2 is prevalently coexpressed with Calb and Ahd2 and only marginally with Girk2, which is in turn confined to dorsallateral VTA neurons coexpressing high levels of glyco-Dat 30, 38 . Using loss-and gain-of-function mouse models, we investigated whether Otx2 is required to provide VTA neurons with specific identity and functional features. We found that Otx2 is required in the VTA to specify neuronal subtype identity and may be involved in the regulation of dopamine metabolism by restricting efficient dopamine uptake to the Otx2-negative neurons of SNpc and dorsal-lateral VTA.
RESULTS
Mouse models used to study Otx2 in adult mdDA neurons We investigated the role of Otx2 in adult mdDA neurons by analyzing the phenotype of mice lacking Otx2 in the VTA and that of mice with one or more additional copies of the Otx2 gene, corresponding to increasing amount of Otx2 protein, in the SNpc and VTA. We employed a Cre mouse model in which the Ires-Cre recombinase (ICre) was inserted into the 3′ untranslated region of the Dat gene (Dat ICre/+ ; Dat is also known as Slc6a3) 41 without affecting Dat synthesis.
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In parallel, we used the Dat ICre/+ mice to generate an allelic series of conditional mutants that overexpress Otx2 at different dosages. We employed the tOtx2 ov/+ transgenic mouse model 6 and a new mutant carrying a conditional Otx2 allele in the Rosa26 (R26) locus (R26 Otx2/+ ; Supplementary Fig. 1 and Online Methods). To assess the functionality of the R26 Otx2 allele and the relative level of Otx2 protein expression, we inserted the CreER recombinase into the second R26 allele of the R26 Otx2/+ embryonic stem cell clone. The level of the Otx2 protein was assayed by western blot 24 h after 4-hydroxytamoxifen (tamoxifen) administration and compared with untreated R26 Otx2/CreER embryonic stem cells and tamoxifen-treated R26 CreER/+ ; tOtx2 ov/+ embryonic stem cells 6 . As deduced by densitometric analysis, Otx2 expression in R26 Otx2/CreER embryonic stem cells was about 1.5-and 3-fold higher than that detected in tamoxifen-treated R26 CreER/+ ; tOtx2 ov/+ and untreated R26 Otx2/CreER embryonic stem cells, respectively (Supplementary Fig. 1c) (Fig. 1g-l and data not shown). In all of these mutants, Otx2 activation was ubiquitously detected in mdDA neurons with an increasing intensity paralleling the number of activated copies of the Otx2 gene (Fig. 1g- (Fig. 1h-j) . All of these mutants were healthy, fertile and apparently normal. Table 1) .
We investigated whether the identity of GFP-positive neurons was altered in the absence of Otx2 by determining the percentage of GFPpositive neurons that coexpressed Calb, Ahd2 or Girk2 (Fig. 2b-n) . A similar percentage of GFP and Calb double-positive and GFP and Ahd2 double-positive neuronal subsets was detected in control and mutant mice (Fig. 2b,g-j) , whereas the percentage of GFP and Girk2 double-positive neurons markedly increased in mice lacking Otx2 (P << 0.001; Fig. 2b ,k-n and Supplementary Table 1 ). This increase was particularly evident in the central VTA (Fig. 2m,n) . In mutants lacking Otx2, we analyzed the expression of Pitx3, Foxa2 and Nurr1, which are crucial for the establishment and survival of mdDA neurons 4, 25, 43 , and detected no evident abnormalities in the expression of these genes ( Supplementary Fig. 2a-f) . These findings indicate that Otx2 is not required for survival of VTA neurons and expression of Calb, Ahd2, Pitx3, Nurr1 or Foxa2, but it is required to antagonize Girk2 (a marker of the dorsal-lateral VTA) expression in neurons of the central VTA.
We investigated whether ectopic expression of Otx2 in tyrosine hydroxylase-positive, Otx2-negative neurons of SNpc and VTA and a r t I C l e S overexpression in tyrosine hydroxylase and Otx2 double-positive VTA neurons affects the survival and/or identity of these neurons. In all of the genetic combinations that we analyzed (n = 10), the number of SNpc and VTA neurons was very similar to that of Dat ICre/+ control mice (P ≥ 0.22 for SNpc, P ≥ 0.24 in VTA; Supplementary Fig. 3 and Supplementary Table 1) . Analysis of tyrosine hydroxylase-positive subpopulations expressing Calb, Ahd2 or Girk2 revealed that there were no significant difference in the SNpc of Dat ICre/+ ; R26 Otx2/Otx2 (n = 7) and Dat ICre/+ ; R26 Otx2/Otx2 ; tOtx2 ov/ov (n = 7) mice (P ≥ 0.1 for Calb, P ≥ 0.18 for Ahd2, P ≥ 0.12 for Girk2; Supplementary Fig. 4 ), whereas there was a significant reduction in the percentage of Girk2 and tyrosine hydroxylase doublepositive neurons in the VTA of these mutants (P < 0.001; Fig. 3 and Supplementary Table 1) . Notably, few Girk2-positive neurons were detected in the lateral-dorsal corner of the VTA of the Otx2 mutant mice, where they are normally confined ( Fig. 3h-j) . Finally, we monitored the expression of Pitx3, Foxa2 and Nurr1; as previously seen in mutants lacking Otx2, expression of these genes was not altered (Supplementary Fig. 2g-r) . These findings are consistent with previous results on mice lacking Otx2 and indicate that Otx2 is apparently unable to affect identity and/or survival of SNpc neurons, even at high dosage. Moreover, the fact that we found no substantial abnormalities in Dat ICre/+ ; R26 Otx2/+ and Dat ICre/+ ; tOtx2 ov/ov mice (data not shown), which express a lower level of Otx2, suggests that Otx2 may alter the expression of Girk2 in the VTA only at a level similar to that of the endogenous gene.
Otx2 confines high glyco-Dat to dorsal-lateral VTA neurons
Proper dopamine uptake represents a crucial step for dopamine signaling. This event is controlled by the distribution and membrane concentration of the glycosylated form of Dat 30 , which is highly expressed in the somata of nigrostriatal SNpc neurons, but is excluded from the majority of mesolimbic VTA neurons 30, 44, 45 . We examined Otx2 and glyco-Dat expression in wild-type mice using an antibody to glyco-Dat 30 . We found that the expression of Otx2 and glyco-Dat was largely complementary in the VTA (Fig. 4a,b) , indicating that Otx2 is prevalently expressed in neurons with a reduced dopamine uptake. In addition, glyco-Dat colocalized with Girk2 expression (Fig. 4c,d) . We therefore analyzed whether loss or ectopic expression of Otx2 may influence the expression and distribution of glyco-Dat. We found that the percentage of GFP and glyco-Dat double-positive neurons was significantly higher in Dat ICre/+ ; Otx2 GFP/loxP mutants (24% versus 15% of control mice, P << 0.001; Fig. 4e-i and Supplementary Table 1) and, as for Girk2, the number of GFP and glyco-Dat double-positive neurons was increased prevalently in the central VTA (Fig. 4h) . Consistent with this, the striatal amount of glyco-Dat and the percentage of SNpc and VTA tyrosine hydroxylase-positive neurons expressing a high level of glyco-Dat was markedly diminished in Dat ICre Fig. 5 and Supplementary Table 2 ). These data suggest that Otx2 is required (Fig. 5a ), suggesting that the diminished level of glyco-Dat does not reflect an impairment in the glycosylation process. Using semiquantitative reverse transcription (RT)-PCR, we examined Dat mRNA expression. Dat mRNA expression was significantly decreased in Dat ICre/+ ; R26 Otx2/Otx2 ; tOtx2 ov/ov mutants (about 65% by densitometric scanning), whereas there was virtually no difference in tyrosine hydroxylase and Nurr1 expression between mutants and control mice (Fig. 5b) . We carried out in situ hybridization experiments and compared the distribution and amount of Dat mRNA with that of glyco-Dat. We found that, compared with control brain, the number of neurons expressing high levels of Dat mRNA and glyco-Dat was increased in the central VTA of Dat ICre/+ ; Otx2 GFP/loxP mice (Fig. 5c-f) , whereas the number of neurons was heavily diminished in both SNpc and VTA of Dat ICre/+ ; R26 Otx2/Otx2 ; tOtx2 ov/ov mutants (Fig. 5g-n) . Together, these findings suggest that reduced synthesis of glyco-Dat is primarily caused by an Otx2-mediated negative control of Dat mRNA level. This control, however, may be direct or indirect.
Otx2 controls SNpc and VTA differential MPTP sensitivity Glyco-Dat efficiently binds the dopamine analog neurotoxin MPTP 30, 31, 46, 47 . We examined whether Otx2 depletion in the VTA or its ectopic expression in SNpc and in all of the VTA neurons alter the vulnerability of these neurons to MPTP-induced neurodegeneration.
We compared VTA neuronal cell numbers and determined the ratio of MPTP-treated (n = 10 mice per genotype) to untreated (n = 10 mice per genotype) VTA neurons respectively in 14-16-week-old control and mutant brains ( Fig. 6 and Supplementary Table 3) .
We first calculated the numbers of tyrosine hydroxylase-positive, GFP and tyrosine hydroxylase double-positive, and GFP-negative, tyrosine hydroxylase-positive neurons in the VTA of MPTP-treated (100 mg per kg of body weight) and untreated Dat ICre/+ ; Otx2 GFP/+ control and Dat ICre/+ ; Otx2 GFP/loxP mutant mice. In this context, GFPnegative, tyrosine hydroxylase-positive neurons represented an internal control, as, in principle, they should not be additionally affected by the lack of Otx2.
We found that, although the numbers of tyrosine hydroxylasepositive, GFP and tyrosine hydroxylase double-positive, and GFPnegative, tyrosine hydroxylase-positive neurons in untreated mice were very similar in controls and mutants ( Fig. 2a and Supplementary  Table 3 ), there was a significant reduction in the number of tyrosine hydroxylase-positive neurons (P < 0.001) and GFP and tyrosine hydroxylase double-positive neurons (P = 0.005) in MPTP-treated Dat ICre/+ ; Otx2 GFP/loxP mutant mice (Fig. 6a and Supplementary Table 3) . Notably, the GFP-negative, tyrosine hydroxylase-positive neuronal subset was not significantly affected by the MPTP treatment (P = 0.4; Fig. 6a and Supplementary Table 3) . We then determined the ratio between MPTP-treated and untreated neuronal subpopulations in control and mutant mice. In control mice, MPTP treatment resulted in a 15% reduction of total tyrosine hydroxylase-positive neurons (Fig. 6c) ; comparing the number of tyrosine hydroxylase-positive neurons that expressed Otx2 (GFP and tyrosine hydroxylase double positive) or did not express Otx2 (GFP negative, tyrosine hydroxylase positive) revealed that the vulnerability to MPTP was much higher for the GFP-negative, tyrosine hydroxylase-positive neuronal subset (24% reduction of GFP-negative, tyrosine hydroxylase-positive subset versus 8% reduction of the GFP and tyrosine hydroxylase double-positive ; tOtx2 ov/ov mice with antibodies to Calb and tyrosine hydroxylase (b-d), Ahd2 and tyrosine hydroxylase (e-g), and Girk2 and tyrosine hydroxylase (h-j). Although no obvious abnormalities were detected for Calb and Ahd2, the number of Girk2-positive neurons and the intensity of their staining were reduced in Otx2-overexpressing mutants (arrows in h-j). Scale bar represents 100 μm. a r t I C l e S subset; Fig. 6c) , and similar to that observed for SNpc neurons in wild-type (data not shown) or Dat ICre/+ control mice (Fig. 6f) . Compared with control mice, the ratio between MPTP-treated and untreated total tyrosine hydroxylase-positive neurons in Dat ICre/+ ; Otx2 GFP/loxP mutants was diminished by ~8% (P = 0.001; Fig. 6c and Supplementary Table 3), but this reduction was almost completely a result of a loss of GFP and tyrosine hydroxylase double-positive neurons (78% versus 92% of control mice, P << 0.001; Fig. 6c ). No significant difference was observed for the GFP-negative, tyrosine hydroxylase-positive subpopulation in control and mutant mice (73% versus 76% of control mice, P = 0.1; Fig. 6c) . We examined whether this neuroprotection was effective at a higher MPTP concentration (125 mg per kg; Fig. 6b,d) . Compared with control mice (n = 8), Dat ICre/+ ; Otx2 GFP/loxP (n = 8) mutants exhibited a 12% and 17% reduction of total tyrosine hydroxylase-positive (70% versus 82% of control mice, P << 0.001) and GFP and tyrosine hydroxylase doublepositive (73% versus 90% of control mice, P << 0.001) neurons. No significant difference was observed for the GFP-negative, tyrosine hydroxylase-positive subset (66% versus 63% of control embryos, P = 0.15; Fig. 6b,d and Supplementary Table 3) . Notably, the vulnerability of VTA neurons lacking Otx2 was similar to that of SNpc neurons Dat ICre/+ ; Otx2 GFP/+ mice (Fig. 6d and Supplementary Table 3 ).
These findings indicate that Otx2 may selectively provide Otx2 (GFP) and tyrosine hydroxylase double-positive VTA neurons with reduced vulnerability to MPTP, the Otx2 (GFP)-negative, tyrosine hydroxylase-positive VTA subpopulation, which consists of Girk2-positive neurons expressing high levels of glyco-Dat, exhibits a sensitivity to MPTP similar to that of SNpc neurons, and, in the absence of Otx2, the vulnerability of VTA neurons is similar to that of SNpc neurons.
We then investigated whether ubiquitous activation of Otx2 was able to provide SNpc and VTA neurons with resistance to MPTP. Untreated and MPTP-treated (100 mg per kg) 14-16-week-old Dat ICre/+ (n = 10) control mice were compared with Dat ICre/+ ; R26 Otx2/Otx2 (n = 10), Dat ICre/+ ; R26 Otx2/Otx2 ; tOtx2 ov/ov (n = 10) and Dat ICre/+ ; R26 Otx2/+ (n = 10) mutants.
We found that, compared with Dat ICre/+ control mice, the number of total tyrosine hydroxylase-positive neurons detected in Dat ICre/+ ; R26 Otx2/Otx2 and Dat ICre/+ ; R26 Otx2/Otx2 ; tOtx2 ov/ov mutants after MPTP treatment was markedly higher in both SNpc (double mutant, P << 0.001; triple mutant, P << 0.001) and VTA (double mutant, P < 0.001; triple mutant, P << 0.001) (Fig. 6e and Supplementary Table 3) . The ratio between MPTP-treated and untreated neurons in SNpc and VTA confirmed that Otx2 activation in Dat ICre/+ ; R26 Otx2/Otx2 ; tOtx2 ov/ov and 
r t I C l e S
Dat ICre/+ ; R26 Otx2/Otx2 mice efficiently protected SNpc (double mutant, P < 0.001; triple mutant, P < 0.001) and VTA (double mutant, P = 0.0018; triple mutant, P << 0.001) neurons from MPTP neurotoxicity (Fig. 6f) . In particular, Dat ICre/+ ; R26 Otx2/Otx2 ; tOtx2 ov/ov mice appeared to be almost completely insensitive to MPTP. Conversely, in Dat ICre/+ ; R26 Otx2/+ mice, a modest neuroprotection was detected (data not shown), suggesting that the Otx2 neuroprotective effect is dose dependent and may be conferred on SNpc neurons and the Otx2-negative VTA neuronal fraction. 
On the whole, this analysis suggests that Otx2 may contribute to the differential vulnerability of SNpc and VTA to MPTP.
DISCUSSION
Previous studies have suggested that Otx2 is crucial for mesDA neurogenesis, although it is apparently not required for differentiation of mdDA neurons of more anterior pretectal origin 6, [27] [28] [29] . We recently found that in adult brains Otx2 expression is excluded from SNpc and restricted to neurons of the central and medial-ventral VTA, where it is coexpressed with Calb and/or Ahd2. Otx2 expression is indeed prevalently excluded from the majority of Girk2-positive neurons of the lateral-dorsal VTA 38 . This restricted expression led us to investigate whether Otx2 is required to control molecular identity and functional features of adult VTA neurons.
Lack of Otx2 in neurons of the central VTA induced the expression of Girk2, which is confined to neurons of the dorsal-lateral VTA (Supplementary Fig. 6 ). Consistent with this, robust activation of Otx2 in the Otx2-negative fraction of VTA neurons generated a relevant reduction in the number of Girk2-positive neurons (Supplementary Fig. 6 ). This suggests that Otx2 is cell autonomously required in neurons of the central VTA to antagonize identity features of the dorsal-lateral VTA.
During embryogenesis, Otx2 is involved in defining the border between adjacent territories or compartments, as in the case of the midbrain-hindbrain border or between progenitors of the mesDA and red nucleus compartments 27, 28 . In these processes, Otx2 operates as a repressing factor by interacting with co-repressing molecules such as Grg4 (refs. 27,28,48) . Our data do not exclude the possibility that VTA neurons are distributed in compartment-like subregions whose identities are maintained by a molecular code of transcription factors, together with positive and negative interacting co-factors. In this context, Otx2 may represent one of these factors whose competence appears to be limited to determining the identity of central VTA and/or presumptive border between central and dorsal-lateral VTA. We investigated whether Otx2 is involved in determining the function of VTA neurons. We analyzed the distribution of glyco-Dat, which is required for the uptake of both dopamine and the dopamine analog toxin MPTP 30, 31 . Notably Otx2 was expressed in neurons with low amounts of glyco-Dat.
Lack of Otx2 resulted in an increase of GFP and glyco-Dat doublepositive neurons in mutants, whereas activation of Otx2 generated a reduction in the number of neurons expressing high amount of glycoDat (Supplementary Fig. 6 ). This suggests that Otx2 is involved in dopamine signaling by suppressing excessive dopamine uptake in Otx2-positive neurons of the central VTA and confining those with efficient dopamine uptake to the dorsal-lateral VTA (Supplementary Fig. 6 ). Via this control, Otx2 may help define the VTA map of dopamine uptake. At the molecular level, our data indicate that Otx2 modulates glyco-Dat levels by negatively controlling (directly or indirectly) the level of Dat mRNA rather than the glycosylation process. An attractive possibility is that, in the central VTA, Otx2 may affect Dat expression in antagonism with Nurr1, which is required for Dat expression 12, 25, 49 .
One consequence of Otx2 ablation in the VTA is an increased vulnerability to the MPTP toxin, likely a result of a higher level of glycoDat and consequent increase of MPTP internalization 30, 31 . Consistent with this, mice that lack Otx2 and are exposed to MPTP showed a significant (P << 0.001) and specific loss of GFP and tyrosine hydroxylase double-positive neurons, which exhibit high resistance to MPTP toxicity in control mice. In contrast, the Otx2-negative population of VTA neurons in both control and mutant mice had a similar and more pronounced sensitivity to MPTP.
These findings suggest that the vulnerability to MPTP converges toward the existence of at least two major functionally distinct subpopulations of VTA neurons. The molecular mechanisms underlying the differential vulnerability of SNpc and VTA neurons to MPTP and Parkinsonian neurodegeneration remain unknown. Notably, the MPTP vulnerability exhibited by the VTA neurons of mice lacking Otx2 is comparable to that of SNpc neurons from wild-type mice and robust ectopic expression of Otx2 in SNpc generates high resistance of these SNpc neurons to MPTP.
These findings suggest that Otx2 is responsible, at least in part, for the differential vulnerability of SNpc and VTA neurons to MPTPinduced neurodegeneration.
Although Dat expression was altered, Girk2, Ahd2, Calb, Pitx3, Foxa2 and Nurr1 were expressed normally in the SNpc of mutants activating Otx2, suggesting that factors other than Otx2 may be required for SNpc neuronal identity. This is similar to findings previously reported for mdDA progenitors in pretectum and mesencephalon, both expressing Otx2, but with only those belonging to the mesencephalon responding to gain or loss of Otx2 (ref. 6 ).
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
